Loomis, Sayles & Company’s Marex Group Limited Ordinary Shares MRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99.1M Sell
1,626,702
-291,920
-15% -$16.1M 0.12% 62
2026
Q1
$85.5M Sell
1,918,622
-16,881
-0.9% -$667K 0.12% 66
2025
Q4
$74.2M Buy
1,935,503
+148,736
+8% +$5.06M 0.09% 69
2025
Q3
$60.1M Buy
1,786,767
+19,335
+1% +$698K 0.07% 93
2025
Q2
$69.8M Buy
1,767,432
+313,411
+22% +$13M 0.09% 81
2025
Q1
$51.4M Buy
+1,454,021
New +$50.6M 0.07% 97

Other funds holding MRX

Loomis, Sayles & Company's MRX Position: Q2 2026 in Review

Loomis, Sayles & Company reduced its Marex Group Limited Ordinary Shares (MRX) stake by 15% in Q2 2026, selling an estimated $16.1M and leaving 1,626,702 shares worth $99.1M. The position accounts for 0.12% of the portfolio, ranked #62.

Loomis, Sayles & Company first reported a position in MRX in Q1 2025 and has held it in 6 quarters since. 221 funds tracked by Wall St. Rank hold MRX as of Q2 2026.

  • Loomis, Sayles & Company held 1,626,702 shares of Marex Group Limited Ordinary Shares worth $99.1M as of Q2 2026.
  • Loomis, Sayles & Company sold 291,920 Marex Group Limited Ordinary Shares shares in Q2 2026, an estimated $16.1M.
  • Marex Group Limited Ordinary Shares made up 0.12% of Loomis, Sayles & Company's portfolio in Q2 2026, its #62 holding.
  • Loomis, Sayles & Company first reported a position in Marex Group Limited Ordinary Shares in Q1 2025 and has held it in 6 quarters since.
  • 221 funds tracked by Wall St. Rank held Marex Group Limited Ordinary Shares as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.